Description

Citicolin Solution for Injections 1000 mg/4 ml. 4 ml. Ampoules №10

Ingredients:

Each 4 ml ampoule contains 1000 mg of Citicoline.

Mechanism of Action:

Citicolin, also known as CDP-choline, acts as a prodrug of choline. It exerts its clinical effects by increasing the levels of neurotransmitters like acetylcholine and phosphatidylcholine in the brain, thereby enhancing cognitive function and supporting brain health.

Pharmacological Properties:

Citicolin exhibits neuroprotective properties and is known for its cognitive-enhancing effects. It plays a crucial role in improving memory and cognitive function, especially in conditions like acute ischemic stroke, traumatic brain injury, and cognitive disorders of vascular origin.

Indications for Use:

Citicolin solution is indicated for the treatment of acute ischemic stroke, traumatic brain injury, and cognitive disorders of vascular origin. It is recommended for patients requiring cognitive support and neurological recovery in these conditions.

Contraindications:

Avoid using Citicolin solution in patients with a known hypersensitivity to the active ingredient or any other component of the formulation. It is essential to perform a thorough evaluation of patient allergies before initiating treatment with Citicolin.

Side Effects:

Citicolin is generally well-tolerated with minimal side effects. However, some individuals may experience mild gastrointestinal disturbances or allergic reactions. In case of any adverse effects, discontinue use and consult a healthcare provider.

Usage Instructions:

The usual dosage of Citicolin solution is 1000 mg (1 ampoule) per day, administered via intramuscular or intravenous injection. It is crucial to follow the dosage recommendations provided by a healthcare professional and not exceed the prescribed amount.

Benefits Compared to Analogues:

Citicolin has shown superior efficacy in improving cognitive function and neurological outcomes compared to other cognitive enhancers. Its neuroprotective properties and well-established safety profile make it a preferred choice for patients requiring cognitive support.

Suitable Patient Groups:

Citicolin solution is suitable for a wide range of patient groups, including adults, elderly individuals, and patients with cognitive impairments. It can be safely administered to children under appropriate medical supervision.

Storage Conditions and Shelf Life:

• Store Citicolin solution in a cool, dry place away from direct sunlight to maintain its stability and efficacy.
• Check the expiration date on the packaging and do not use the product beyond the indicated shelf life.

Packaging Description:

Citicolin solution is available in 4 ml ampoules, with each containing 1000 mg of Citicoline. The packaging includes 10 ampoules per pack, ensuring an adequate supply for the prescribed treatment duration.

Clinical Evidence and Proven Effectiveness:

Several clinical studies have demonstrated the efficacy of Citicolin in improving cognitive function and neurological outcomes in patients with acute ischemic stroke and traumatic brain injury. Research has shown that Citicolin treatment leads to significant reductions in neurological deficits and improved functional recovery compared to placebo.